Page last updated: 2024-09-04

naproxen and Hyperamylasemia

naproxen has been researched along with Hyperamylasemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasandokht, T; Joukar, F; Mansour-Ghanaei, F; Sokhanvar, H; Taherzadeh, Z	1

Trials

1 trial(s) available for naproxen and Hyperamylasemia

Article	Year
Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. World journal of gastroenterology, 2016, Jun-07, Volume: 22, Issue:21 Topics: Abdominal Pain; Administration, Rectal; Adult; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi-Square Distribution; Cholangiopancreatography, Endoscopic Retrograde; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperamylasemia; Iran; Male; Middle Aged; Naproxen; Odds Ratio; Pancreatitis; Risk Factors; Severity of Illness Index; Suppositories; Time Factors; Treatment Outcome; Up-Regulation	2016

Article

Year

Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

World journal of gastroenterology, 2016, Jun-07, Volume: 22, Issue:21

Topics: Abdominal Pain; Administration, Rectal; Adult; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi-Square Distribution; Cholangiopancreatography, Endoscopic Retrograde; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperamylasemia; Iran; Male; Middle Aged; Naproxen; Odds Ratio; Pancreatitis; Risk Factors; Severity of Illness Index; Suppositories; Time Factors; Treatment Outcome; Up-Regulation

2016